BRD2 Antikörper
-
- Target Alle BRD2 Antikörper anzeigen
- BRD2 (Bromodomain Containing 2 (BRD2))
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BRD2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of Brd2.
- Immunogen
- A synthetic peptide (conjugated with KLH) corresponding to internal region of mouse Brd2.
- Top Product
- Discover our top product BRD2 Primärantikörper
-
anti-Bromodomain Containing 2 (BRD2) (AA 227-364) antibody
BRD2 Reaktivität: Human, Ratte WB, ELISA, IHC, ICC, FACS Wirt: Maus Monoclonal 7C1B10 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 167-256) antibodyBRD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3D10 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-100) antibodyBRD2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 170-200) antibodyBRD2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB3416 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 524-573) antibodyBRD2 Reaktivität: Human, Maus, Rind (Kuh), Hund, Ratte, Pferd, Schwein, Hamster, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 227-364) antibodyBRD2 Reaktivität: Human WB, ELISA, IHC, ICC, FACS Wirt: Maus Monoclonal 1H6B12 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-801) antibodyBRD2 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-801) antibodyBRD2 Reaktivität: Human IP Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (C-Term) antibodyBRD2 Reaktivität: Human, Hamster WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (Internal Region) antibodyBRD2 Reaktivität: Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA (1:50-1:200)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In serum (0.05 % sodium azide)
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
-
Store at -20°C. For long term storage store at -80°C.
Aliquot to avoid repeated freezing and thawing.
-
- Target
- BRD2 (Bromodomain Containing 2 (BRD2))
- Andere Bezeichnung
- BRD2 (BRD2 Produkte)
- Synonyme
- D6S113E antikoerper, FSH antikoerper, FSRG1 antikoerper, NAT antikoerper, RING3 antikoerper, RNF3 antikoerper, AW228947 antikoerper, D17H6S113E antikoerper, Frg-1 antikoerper, Fsrg-1 antikoerper, Fsrg1 antikoerper, Nat antikoerper, Ring3 antikoerper, Rnf3 antikoerper, mKIAA4005 antikoerper, brd2-a antikoerper, fsh antikoerper, fsrg1 antikoerper, nat antikoerper, ring3 antikoerper, rnf3 antikoerper, brd2 antikoerper, fe47f02 antikoerper, fi85h05 antikoerper, wu:fe47f02 antikoerper, wu:fi85h05 antikoerper, Ring3 protein antikoerper, bromodomain containing 2 antikoerper, bromodomain containing 2 S homeolog antikoerper, bromodomain containing 2a antikoerper, CHLREDRAFT_190116 antikoerper, CHLREDRAFT_150233 antikoerper, CHLREDRAFT_182576 antikoerper, CHLREDRAFT_188250 antikoerper, BRD2 antikoerper, Brd2 antikoerper, brd2.S antikoerper, brd2a antikoerper
- Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-
